The U.S. Food and Drug Administration is pushing to cut salt levels by an average of 12 percent in food ranging from packaged meats to cheese, trying to clamp down on a growing epidemic of preventable health issues that has plagued the country.

An investigational medicine in late-stage development by Jazz Pharmaceuticals hit the mark in treating cataplexy and excessive daytime sleepiness (EDS) in adults with narcolepsy.